Newborn screening for medium chain acyl CoA dehydrogenase deficiency

Archives of Disease in Childhood

Volumn 94, Issue 3, 2009, Pages 235-238

  Leonard, J V ^a,b   Dezateux, C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CARNITINE; GLUCOSE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

AUTOSOMAL RECESSIVE DISORDER; CARBOHYDRATE DIET; CHILD HEALTH CARE; CLINICAL PROTOCOL; DIAGNOSTIC TEST; EMERGENCY CARE; ENZYME DEFICIENCY; FAMILY COUNSELING; FAMILY STUDY; FATTY ACID OXIDATION; HUMAN; IMMUNIZATION; INBORN ERROR OF METABOLISM; NEWBORN; NEWBORN SCREENING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIBLING; TANDEM MASS SPECTROMETRY;

ACYL-COA DEHYDROGENASE; EMERGENCIES; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; NEONATAL SCREENING;

EID: 61449153832     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.134957     Document Type: Review

References (38)

1. Roe CR, Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited disease. 8th edn. New York: McGraw-Hill, 2001:2297-326.
2. Pollitt RJ, Leonard JV. Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child 1998;79:116-19.
3. Hoffmann GF, von Kries R, Klose D, et al. Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur J Pediatr 2004;163:76-80.
4. Derks TG, Duran M, Waterham HR, et al. The difference between observed and expected prevalence of MCAD deficiency in The Netherlands: a genetic epidemiological study. Eur J Hum Genet 2005;13:947-52.
5. Klose DA, Kölker S, Heinrich B, et al. Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany. Pediatrics 2002;110:1204-11.
6. Wang SS, Fernhoff PM, Hannon WH, et al. Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med 1999;1:332-9.
7. Wilcken B, Carpenter K, Wiley V. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet 2002;359:627-8.
8. Pourfarzam M, Morris A, Appleton M, et al. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet 2001;358:1063-1.
9. Grosse SD, Khoury MJ, Greene CL, et al. The epidemiology of medium chain acyl- CoA dehydrogenase deficiency: an update. Genet Med 2006;8:205-12.
10. Iafolla AK, Thompson RJ Jr, Roe CR. Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994;124:409-15.
11. Wilson CJ, Champion MP, Collins JE, et al. Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child 1999;80:459-62.
12. Chace DH, DiPerna JC, Mitchell BL, et al. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001;47:1166-82.
13. Duran M, Hofkamp M, Rhead WJ, at al. Sudden child death and 'healthy' affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 1986;78:1052-7.
14. Derks TG, Reijngoud DJ, Waterham HR, et al. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Padiatr 2006;148:665-70.
15. Dixon MA, Leonard JV. Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 1992;67:1387-91.
16. Morris AA, Leonard JV. Early recognition of metabolic decompensation. Arch Dis Child 1997;76:555-6.
17. Stanley CA. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Padiatr 1987;34:59-88.
18. Lee PJ, Harrison EL, Jones MG, at al. L-carnitine and exercise tolerance in medium- chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study. J Inherit Matab Dis 2005;28:141-52.
19. Huidekoper HH, Schneider J, Westphal T, et al. Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency. J Inharit Matab Dis 2006;29:631-6.
20. Stanley CA, Bennet MJ, Mayatapek E. Disorders of fatty acid oxidation and related metabolic pathways. In: Fernandes J, Saububray JM, van den Berghe G, at al, eds. Inborn matabolic disaasas: diagnosis and traatmant. 4th edn. Heidelberg: Springer, 2006:175-90.
21. Walter JH. L-carnitine in inborn errors of metabolism: what is the evidence? J Inharit Matab Dis 2003;26:181-8.
22. Rhead WJ. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective. J Inharit Matab Dis 2006;29:370-7.
23. Clayton PT, Doig M, Ghafari S, et al. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Arch Dis Child 1998;79:109-15.
24. Carpenter K, Wiley V, Sim KG, at al. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child Fatal Naonatal Ed 2001;85:F105-9.
25. Derks TG, Boer TS, van Assen A, et al. Neonatal screening for medium-chain acyl- CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency. J Inharit Matab Dis 2008;31:88-96.
26. Lehotay DC, LePage J, Thompson JR, et al. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype? J Inharit Matab Dis 2004;27:81-8.
27. Andresen BS, Dobrowolski SF, O'Reilly L, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Ganat 2001;68:1408-18.
28. Tanaka K, Gregersen N, Ribes A, et al. A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain acyl- CoA dehydrogenase gene locus: clinical and evolutionary consideration. Padiatr Ras 1997;41:201-9.
29. Gregersen N, Bross P, Andresen BS. Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships. Eur J Biocham 2004;271:470-82.
30. Zschocke J, Schulze A, Lindner M, et al. Molecular and functional characterisation of mild MCAD deficiency. Hum Ganat 2001;108:404-8.
31. Khalid JM, Oerton J, Cortina-Borja M, et al. Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants. J Mad Scraan 2008;15:112-7.
32. Ziadeh R, Hoffman EP, Finegold DN, et al. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Padiatr Ras 1995;37:675-8.
33. Hsu HW, Zytkovicz TH, Comeau AM, et al. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening. Padiatrics 2008;121:e1108-14.
34. Nennstiel-Ratzel U, Arenz S, Maier EM, et al. Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening. Mol Genat Metab 2005;85:157-9.
35. NHS. Antenatal and newborn screening programmes. MCADD Screening Programme. See http://www.newbornbloodspot.screening.nhs.uk/mcadd/index.htm (accessed 29 October 2008).
36. British Inherited Metabolic Disease Group. Emergency protocols. MCAD deficiency guidelines. See http://www.bimdg.org.uk/mcadd.asp?TopicID=11 (accessed 29 October 2008).
37. Ruitenbeek W, Poels PJ, Turnbull DM, et al. Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Naurol Naurosurg Psychiatry 1995;58:209-14.
38. Patel JS, Leonard JV. Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency. J Inharit Matab Dis 1995;18:98-9.